Summary
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
According to APO Research, The global PNH and aHUS market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for PNH and aHUS is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for PNH and aHUS is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for PNH and aHUS is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for PNH and aHUS is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of PNH and aHUS include Alexion Pharmaceuticals, Alnylam Pharmaceuticals and Omeros Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for PNH and aHUS, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of PNH and aHUS, also provides the revenue of main regions and countries. Of the upcoming market potential for PNH and aHUS, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the PNH and aHUS revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global PNH and aHUS market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for PNH and aHUS revenue, projected growth trends, production technology, application and end-user industry.
PNH and aHUS segment by Company
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation
PNH and aHUS segment by Type
Soliris
Ultomiris
PNH and aHUS segment by Application
PNH
aHUS
PNH and aHUS segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PNH and aHUS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PNH and aHUS and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PNH and aHUS.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of PNH and aHUS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of PNH and aHUS company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PNH and aHUS revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 PNH and aHUS Market by Type
1.2.1 Global PNH and aHUS Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Soliris
1.2.3 Ultomiris
1.3 PNH and aHUS Market by Application
1.3.1 Global PNH and aHUS Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 PNH
1.3.3 aHUS
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PNH and aHUS Market Dynamics
2.1 PNH and aHUS Industry Trends
2.2 PNH and aHUS Industry Drivers
2.3 PNH and aHUS Industry Opportunities and Challenges
2.4 PNH and aHUS Industry Restraints
3 Global Growth Perspective
3.1 Global PNH and aHUS Market Perspective (2019-2030)
3.2 Global PNH and aHUS Growth Trends by Region
3.2.1 Global PNH and aHUS Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global PNH and aHUS Market Size by Region (2019-2024)
3.2.3 Global PNH and aHUS Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global PNH and aHUS Revenue by Players
4.1.1 Global PNH and aHUS Revenue by Players (2019-2024)
4.1.2 Global PNH and aHUS Revenue Market Share by Players (2019-2024)
4.1.3 Global PNH and aHUS Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global PNH and aHUS Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global PNH and aHUS Key Players Headquarters & Area Served
4.4 Global PNH and aHUS Players, Product Type & Application
4.5 Global PNH and aHUS Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global PNH and aHUS Market CR5 and HHI
4.6.2 Global Top 5 and 10 PNH and aHUS Players Market Share by Revenue in 2023
4.6.3 2023 PNH and aHUS Tier 1, Tier 2, and Tier 3
5 PNH and aHUS Market Size by Type
5.1 Global PNH and aHUS Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global PNH and aHUS Revenue by Type (2019-2030)
5.3 Global PNH and aHUS Revenue Market Share by Type (2019-2030)
6 PNH and aHUS Market Size by Application
6.1 Global PNH and aHUS Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global PNH and aHUS Revenue by Application (2019-2030)
6.3 Global PNH and aHUS Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Alexion Pharmaceuticals
7.1.1 Alexion Pharmaceuticals Comapny Information
7.1.2 Alexion Pharmaceuticals Business Overview
7.1.3 Alexion Pharmaceuticals PNH and aHUS Revenue and Gross Margin (2019-2024)
7.1.4 Alexion Pharmaceuticals PNH and aHUS Product Portfolio
7.1.5 Alexion Pharmaceuticals Recent Developments
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Comapny Information
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals PNH and aHUS Revenue and Gross Margin (2019-2024)
7.2.4 Alnylam Pharmaceuticals PNH and aHUS Product Portfolio
7.2.5 Alnylam Pharmaceuticals Recent Developments
7.3 Omeros Corporation
7.3.1 Omeros Corporation Comapny Information
7.3.2 Omeros Corporation Business Overview
7.3.3 Omeros Corporation PNH and aHUS Revenue and Gross Margin (2019-2024)
7.3.4 Omeros Corporation PNH and aHUS Product Portfolio
7.3.5 Omeros Corporation Recent Developments
8 North America
8.1 North America PNH and aHUS Revenue (2019-2030)
8.2 North America PNH and aHUS Revenue by Type (2019-2030)
8.2.1 North America PNH and aHUS Revenue by Type (2019-2024)
8.2.2 North America PNH and aHUS Revenue by Type (2025-2030)
8.3 North America PNH and aHUS Revenue Share by Type (2019-2030)
8.4 North America PNH and aHUS Revenue by Application (2019-2030)
8.4.1 North America PNH and aHUS Revenue by Application (2019-2024)
8.4.2 North America PNH and aHUS Revenue by Application (2025-2030)
8.5 North America PNH and aHUS Revenue Share by Application (2019-2030)
8.6 North America PNH and aHUS Revenue by Country
8.6.1 North America PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America PNH and aHUS Revenue by Country (2019-2024)
8.6.3 North America PNH and aHUS Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe PNH and aHUS Revenue (2019-2030)
9.2 Europe PNH and aHUS Revenue by Type (2019-2030)
9.2.1 Europe PNH and aHUS Revenue by Type (2019-2024)
9.2.2 Europe PNH and aHUS Revenue by Type (2025-2030)
9.3 Europe PNH and aHUS Revenue Share by Type (2019-2030)
9.4 Europe PNH and aHUS Revenue by Application (2019-2030)
9.4.1 Europe PNH and aHUS Revenue by Application (2019-2024)
9.4.2 Europe PNH and aHUS Revenue by Application (2025-2030)
9.5 Europe PNH and aHUS Revenue Share by Application (2019-2030)
9.6 Europe PNH and aHUS Revenue by Country
9.6.1 Europe PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe PNH and aHUS Revenue by Country (2019-2024)
9.6.3 Europe PNH and aHUS Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China PNH and aHUS Revenue (2019-2030)
10.2 China PNH and aHUS Revenue by Type (2019-2030)
10.2.1 China PNH and aHUS Revenue by Type (2019-2024)
10.2.2 China PNH and aHUS Revenue by Type (2025-2030)
10.3 China PNH and aHUS Revenue Share by Type (2019-2030)
10.4 China PNH and aHUS Revenue by Application (2019-2030)
10.4.1 China PNH and aHUS Revenue by Application (2019-2024)
10.4.2 China PNH and aHUS Revenue by Application (2025-2030)
10.5 China PNH and aHUS Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia PNH and aHUS Revenue (2019-2030)
11.2 Asia PNH and aHUS Revenue by Type (2019-2030)
11.2.1 Asia PNH and aHUS Revenue by Type (2019-2024)
11.2.2 Asia PNH and aHUS Revenue by Type (2025-2030)
11.3 Asia PNH and aHUS Revenue Share by Type (2019-2030)
11.4 Asia PNH and aHUS Revenue by Application (2019-2030)
11.4.1 Asia PNH and aHUS Revenue by Application (2019-2024)
11.4.2 Asia PNH and aHUS Revenue by Application (2025-2030)
11.5 Asia PNH and aHUS Revenue Share by Application (2019-2030)
11.6 Asia PNH and aHUS Revenue by Country
11.6.1 Asia PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia PNH and aHUS Revenue by Country (2019-2024)
11.6.3 Asia PNH and aHUS Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA PNH and aHUS Revenue (2019-2030)
12.2 MEALA PNH and aHUS Revenue by Type (2019-2030)
12.2.1 MEALA PNH and aHUS Revenue by Type (2019-2024)
12.2.2 MEALA PNH and aHUS Revenue by Type (2025-2030)
12.3 MEALA PNH and aHUS Revenue Share by Type (2019-2030)
12.4 MEALA PNH and aHUS Revenue by Application (2019-2030)
12.4.1 MEALA PNH and aHUS Revenue by Application (2019-2024)
12.4.2 MEALA PNH and aHUS Revenue by Application (2025-2030)
12.5 MEALA PNH and aHUS Revenue Share by Application (2019-2030)
12.6 MEALA PNH and aHUS Revenue by Country
12.6.1 MEALA PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA PNH and aHUS Revenue by Country (2019-2024)
12.6.3 MEALA PNH and aHUS Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global PNH and aHUS Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Soliris Major Manufacturers
Table 2. Ultomiris Major Manufacturers
Table 3. Global PNH and aHUS Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. PNH Major Manufacturers
Table 5. aHUS Major Manufacturers
Table 6. PNH and aHUS Industry Trends
Table 7. PNH and aHUS Industry Drivers
Table 8. PNH and aHUS Industry Opportunities and Challenges
Table 9. PNH and aHUS Industry Restraints
Table 10. Global PNH and aHUS Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global PNH and aHUS Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global PNH and aHUS Market Share by Region (2019-2024)
Table 13. Global PNH and aHUS Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global PNH and aHUS Market Share by Region (2025-2030)
Table 15. Global PNH and aHUS Revenue by Players (US$ Million) & (2019-2024)
Table 16. Global PNH and aHUS Revenue Market Share by Players (2019-2024)
Table 17. Global PNH and aHUS Key Players Ranking, 2022 VS 2023 VS 2024
Table 18. Global PNH and aHUS Key Players Headquarters & Area Served
Table 19. Global PNH and aHUS Players, Product Type & Application
Table 20. Global PNH and aHUS Players Commercialization Time
Table 21. Global Players Market Concentration Ratio (CR5 and HHI)
Table 22. Global PNH and aHUS by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 23. Global PNH and aHUS Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global PNH and aHUS Revenue by Type (2019-2024) & (US$ Million)
Table 25. Global PNH and aHUS Revenue by Type (2025-2030) & (US$ Million)
Table 26. Global PNH and aHUS Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 27. Global PNH and aHUS Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 28. Global PNH and aHUS Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global PNH and aHUS Revenue by Application (2019-2024) & (US$ Million)
Table 30. Global PNH and aHUS Revenue by Application (2025-2030) & (US$ Million)
Table 31. Global PNH and aHUS Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 32. Global PNH and aHUS Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 33. Alexion Pharmaceuticals Company Information
Table 34. Alexion Pharmaceuticals Business Overview
Table 35. Alexion Pharmaceuticals PNH and aHUS Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 36. Alexion Pharmaceuticals PNH and aHUS Product Portfolio
Table 37. Alexion Pharmaceuticals Recent Development
Table 38. Alnylam Pharmaceuticals Company Information
Table 39. Alnylam Pharmaceuticals Business Overview
Table 40. Alnylam Pharmaceuticals PNH and aHUS Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 41. Alnylam Pharmaceuticals PNH and aHUS Product Portfolio
Table 42. Alnylam Pharmaceuticals Recent Development
Table 43. Omeros Corporation Company Information
Table 44. Omeros Corporation Business Overview
Table 45. Omeros Corporation PNH and aHUS Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 46. Omeros Corporation PNH and aHUS Product Portfolio
Table 47. Omeros Corporation Recent Development
Table 48. North America PNH and aHUS Revenue by Type (2019-2024) & (US$ Million)
Table 49. North America PNH and aHUS Revenue by Application (2019-2024) & (US$ Million)
Table 50. North America PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. North America PNH and aHUS Revenue by Country (2019-2024) & (US$ Million)
Table 52. North America PNH and aHUS Revenue by Country (2025-2030) & (US$ Million)
Table 53. Europe PNH and aHUS Revenue by Type (2019-2024) & (US$ Million)
Table 54. Europe PNH and aHUS Revenue by Application (2019-2024) & (US$ Million)
Table 55. Europe PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 56. Europe PNH and aHUS Revenue by Country (2019-2024) & (US$ Million)
Table 57. Europe PNH and aHUS Revenue by Country (2025-2030) & (US$ Million)
Table 58. China PNH and aHUS Revenue by Type (2019-2024) & (US$ Million)
Table 59. China PNH and aHUS Revenue by Application (2019-2024) & (US$ Million)
Table 60. Asia PNH and aHUS Revenue by Type (2019-2024) & (US$ Million)
Table 61. Asia PNH and aHUS Revenue by Application (2019-2024) & (US$ Million)
Table 62. Asia PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 63. Asia PNH and aHUS Revenue by Country (2019-2024) & (US$ Million)
Table 64. Asia PNH and aHUS Revenue by Country (2025-2030) & (US$ Million)
Table 65. MEALA PNH and aHUS Revenue by Type (2019-2024) & (US$ Million)
Table 66. MEALA PNH and aHUS Revenue by Application (2019-2024) & (US$ Million)
Table 67. MEALA PNH and aHUS Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 68. MEALA PNH and aHUS Revenue by Country (2019-2024) & (US$ Million)
Table 69. MEALA PNH and aHUS Revenue by Country (2025-2030) & (US$ Million)
Table 70. Research Programs/Design for This Report
Table 71. Authors List of This Report
Table 72. Secondary Sources
Table 73. Primary Sources
List of Figures
Figure 1. PNH and aHUS Product Picture
Figure 2. Global PNH and aHUS Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global PNH and aHUS Market Size Share 2019 VS 2023 VS 2030
Figure 4. Soliris Picture
Figure 5. Ultomiris Picture
Figure 6. Global PNH and aHUS Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global PNH and aHUS Market Size Share 2019 VS 2023 VS 2030
Figure 8. PNH Picture
Figure 9. aHUS Picture
Figure 10. Global PNH and aHUS Market Size (US$ Million) & (2019-2030)
Figure 11. Global PNH and aHUS Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global PNH and aHUS Market Share by Region: 2019 VS 2023 VS 2030
Figure 13. Global PNH and aHUS Players Revenue Share Top 10 and Top 5 in 2023
Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 15. Global PNH and aHUS Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global PNH and aHUS Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global PNH and aHUS Revenue Market Share by Type (2019-2030)
Figure 18. Global PNH and aHUS Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global PNH and aHUS Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 20. Global PNH and aHUS Revenue Market Share by Application (2019-2030)
Figure 21. North America PNH and aHUS Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America PNH and aHUS Revenue by Type (2025-2030) & (US$ Million)
Figure 23. North America PNH and aHUS Revenue Share by Type (2019-2030)
Figure 24. North America PNH and aHUS Revenue by Application (2025-2030) & (US$ Million)
Figure 25. North America PNH and aHUS Revenue Share by Application (2019-2030)
Figure 26. North America PNH and aHUS Revenue Share by Country (2019-2030)
Figure 27. United States PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 28. Canada PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Europe PNH and aHUS Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe PNH and aHUS Revenue by Type (2025-2030) & (US$ Million)
Figure 31. Europe PNH and aHUS Revenue Share by Type (2019-2030)
Figure 32. Europe PNH and aHUS Revenue by Application (2025-2030) & (US$ Million)
Figure 33. Europe PNH and aHUS Revenue Share by Application (2019-2030)
Figure 34. Europe PNH and aHUS Revenue Share by Country (2019-2030)
Figure 35. Germany PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. France PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. U.K. PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. Italy PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Russia PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Nordic Countries PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. China PNH and aHUS Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 42. China PNH and aHUS Revenue by Type (2025-2030) & (US$ Million)
Figure 43. China PNH and aHUS Revenue Share by Type (2019-2030)
Figure 44. China PNH and aHUS Revenue by Application (2025-2030) & (US$ Million)
Figure 45. China PNH and aHUS Revenue Share by Application (2019-2030)
Figure 46. Asia PNH and aHUS Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 47. Asia PNH and aHUS Revenue by Type (2025-2030) & (US$ Million)
Figure 48. Asia PNH and aHUS Revenue Share by Type (2019-2030)
Figure 49. Asia PNH and aHUS Revenue by Application (2025-2030) & (US$ Million)
Figure 50. Asia PNH and aHUS Revenue Share by Application (2019-2030)
Figure 51. Asia PNH and aHUS Revenue Share by Country (2019-2030)
Figure 52. Japan PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 53. South Korea PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. India PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. Australia PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. China Taiwan PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Southeast Asia PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. MEALA PNH and aHUS Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 59. MEALA PNH and aHUS Revenue by Type (2025-2030) & (US$ Million)
Figure 60. MEALA PNH and aHUS Revenue Share by Type (2019-2030)
Figure 61. MEALA PNH and aHUS Revenue by Application (2025-2030) & (US$ Million)
Figure 62. MEALA PNH and aHUS Revenue Share by Application (2019-2030)
Figure 63. MEALA PNH and aHUS Revenue Share by Country (2019-2030)
Figure 64. Mexico PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. South Korea PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. Brazil PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Israel PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Argentina PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Colombia PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Turkey PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Saudi Arabia PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. UAE PNH and aHUS Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
